Sertraline Polymorph

Sertraline polymorph having improved water solubility - Patent

Abstract of EP0928784 A novel polymorph of sertraline hydrochloride, ie (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthal enamine.

Development of an Aqueous-Based Oral Solution Formulation of

Was used as received. The formulation contained sertraline HCl equivalent to 20 mg/mL sertraline, glycerin, ethanol (10%), menthol, and BHT. Sertraline HCl Polymorph II was.

Condensed Patent Expiration List Products whose first patent

Pat. No. 5248699 Sertraline polymorph Claim Types: New polymorph, salt or hydrate; Composition; Method of use, Feb 13, 2013 *PED.

(WO/2001/032601) POLYMORPHIC FORMS OF SERTRALINE HYDROCHLORIDE

Or recrystallization of any polymorphic form sertraline hydrochloride from water. 16. A process for the preparation of crystalline polymorph of (1 S-cis)-4.

Www.fdli.org

No. 5248699 Sertraline polymorph Claim Types: New polymorph, salt or hydrate; Composition; Method of use : Feb 13, 2013 *PED : Exclusivity Expiration Exclusivity Description.

BigPatents -- Sertraline polymorph

This invention relates to a novel crystalline polymorphic form of sertraline hydrochloride, (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4 -tetrahydro-N-methyl-1-naphthalenamine.

(WO/2002/096859) PROCESS FOR PREPARING SERTRALINE HYDROCHLORIDE

Form II is commercially the most practical form of sertraline polymorph to be used in pharmaceutical formulations. Form I is more stable, but it is not so.

Sertraline polymorph - US Patent 5734083

Sertraline polymorph - US Patent 5734083 from Patent Storm. A novel polymorph of sertraline hydrochloride, i.

BigPatents -- Orange Book

Orange Book. The following is a list of drugs currently approved by the F.D.A. and Sertraline polymorph.

Pharma News Briefs

Reddy's infringed its sertraline HCl polymorph patents. ( Patent Docs ; TMCnet.com ). Imclone and Repligen/MIT settled their patent dispute over Erbitux. ( Patent Prospector.

Sertraline polymorph - Patent 5734083

A novel polymorph of sertraline hydrochloride, ie (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenam ine hydrochloride, is disclosed.

BigPatents -- Sertraline polymorph

Sertraline polymorph. Patent 5248699 issued 1993-09-28 Application 07/929326 filed 1992-08-13. Snapshot References Examination Classifications Transactions.

(WO/2001/032601) POLYMORPHIC FORMS OF SERTRALINE HYDROCHLORIDE

The sertraline hydrochloride polymorph form CSC1 may also be formed by recrystallization of any polymorphic form of sertraline hydrochloride from water.

Sertraline polymorph - US Patent 5734083

Sertraline polymorph - US Patent 5734083 from Patent Storm. A novel polymorph of sertraline hydrochloride, i.

High-throughput crystallization: polymorphs, salts, co-crystals

File Format: PDF/Adobe Acrobat - View as HTMLYour browser may not have a PDF reader available. Google recommends visiting our text version of this document.polymorphs, PCT WO 00/32551. [91] Pfizer, Sertraline polymorph, US Patent #5248699. S.L. Morissette et al. / Advanced Drug Delivery Reviews 56 (2004) 275–.

Www.fdli.org

Claim Types: New polymorph, salt or hydrate; Method of use; Process; Product-by-process; Formulation : Jul 23, 2018: U-470: Therapy in chronic hepatitis B virus infection.

Leydig Voit & Mayer - Intellectual Property Law, Copyright Law

Patent 5,248,699 (relating to crystalline sertraline polymorph). 17 Bayer AG v. Elan Pharmaceutical Research Corp., 212 F.3d 1241, 1246 (Fed.

Sertraline polymorph - US Patent 5734083

Sertraline polymorph - US Patent 5734083 from Patent Storm. A novel polymorph of sertraline hydrochloride, i.

Orange Book Blog: Pharma News Briefs

Reddy's infringed its sertraline HCl polymorph patents. ( Patent Docs ; TMCnet.com ). Imclone and Repligen/MIT settled their patent dispute over Erbitux. ( Patent Prospector ). Ranbaxy.

Sertraline polymorph - Patent 5248699

This invention relates to a novel crystalline polymorphic form of sertraline hydrochloride, (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4.